摘要

Lymphocytic pleurisy is commonly observed in tuberculosis and cancer. Noninvasive biomarkers are needed to distinguish tuberculous pleural effusion (TPE) from malignant pleural effusion (MPE) because current clinical diagnostic procedures are often invasive. We identified immune response biomarkers that can discriminate between TPE and MPE. Fourteen pleural effusion biomarkers were compared in 22 MPE patients and five TPE patients. Of the innate immunity biomarkers, the median levels of interleukin (IL)-1βand interferon-induced protein-10 (IP-10) were higher in TPE patients than in MPE patients (P
原文英語
頁(從 - 到)183-189
頁數7
期刊International Journal of General Medicine
9
DOIs
出版狀態已發佈 - 六月 11 2016

指紋

Malignant Pleural Effusion
Pleural Effusion
Biomarkers
Pleurisy
Interleukins
Innate Immunity
Interferons
Tuberculosis
Neoplasms
Proteins

ASJC Scopus subject areas

  • Medicine(all)

引用此文

@article{ec12553111234ec1be82ba7de2288aa4,
title = "Novel biomarker analysis of pleural effusion enhances differentiation of tuberculous from malignant pleural effusion",
abstract = "Lymphocytic pleurisy is commonly observed in tuberculosis and cancer. Noninvasive biomarkers are needed to distinguish tuberculous pleural effusion (TPE) from malignant pleural effusion (MPE) because current clinical diagnostic procedures are often invasive. We identified immune response biomarkers that can discriminate between TPE and MPE. Fourteen pleural effusion biomarkers were compared in 22 MPE patients and five TPE patients. Of the innate immunity biomarkers, the median levels of interleukin (IL)-1βand interferon-induced protein-10 (IP-10) were higher in TPE patients than in MPE patients (P",
keywords = "Biomarkers, Lung cancer, Malignant pleural effusion, Tuberculous pleural effusion",
author = "Chen, {Kuan Yuan} and Feng, {Po Hao} and Chang, {Chih Cheng} and Chen, {Tzu Tao} and Chuang, {Hsiao Chi} and Lee, {Chun Nin} and Su, {Chien Ling} and Lin, {Lian Yu} and Lee, {Kang Yun}",
year = "2016",
month = "6",
day = "11",
doi = "10.2147/IJGM.S100237",
language = "English",
volume = "9",
pages = "183--189",
journal = "International Journal of General Medicine",
issn = "1178-7074",
publisher = "Dove Medical Press Ltd.",

}

TY - JOUR

T1 - Novel biomarker analysis of pleural effusion enhances differentiation of tuberculous from malignant pleural effusion

AU - Chen, Kuan Yuan

AU - Feng, Po Hao

AU - Chang, Chih Cheng

AU - Chen, Tzu Tao

AU - Chuang, Hsiao Chi

AU - Lee, Chun Nin

AU - Su, Chien Ling

AU - Lin, Lian Yu

AU - Lee, Kang Yun

PY - 2016/6/11

Y1 - 2016/6/11

N2 - Lymphocytic pleurisy is commonly observed in tuberculosis and cancer. Noninvasive biomarkers are needed to distinguish tuberculous pleural effusion (TPE) from malignant pleural effusion (MPE) because current clinical diagnostic procedures are often invasive. We identified immune response biomarkers that can discriminate between TPE and MPE. Fourteen pleural effusion biomarkers were compared in 22 MPE patients and five TPE patients. Of the innate immunity biomarkers, the median levels of interleukin (IL)-1βand interferon-induced protein-10 (IP-10) were higher in TPE patients than in MPE patients (P

AB - Lymphocytic pleurisy is commonly observed in tuberculosis and cancer. Noninvasive biomarkers are needed to distinguish tuberculous pleural effusion (TPE) from malignant pleural effusion (MPE) because current clinical diagnostic procedures are often invasive. We identified immune response biomarkers that can discriminate between TPE and MPE. Fourteen pleural effusion biomarkers were compared in 22 MPE patients and five TPE patients. Of the innate immunity biomarkers, the median levels of interleukin (IL)-1βand interferon-induced protein-10 (IP-10) were higher in TPE patients than in MPE patients (P

KW - Biomarkers

KW - Lung cancer

KW - Malignant pleural effusion

KW - Tuberculous pleural effusion

UR - http://www.scopus.com/inward/record.url?scp=84975297493&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84975297493&partnerID=8YFLogxK

U2 - 10.2147/IJGM.S100237

DO - 10.2147/IJGM.S100237

M3 - Article

AN - SCOPUS:84975297493

VL - 9

SP - 183

EP - 189

JO - International Journal of General Medicine

JF - International Journal of General Medicine

SN - 1178-7074

ER -